A 71-years-old lady, Mrs. IZ (PIN 31174) hailing from Madhya Pradesh started the treatment for Trigeminal Neuralgia with Life Force on 2nd February 2017. Since patient could not travel to Mumbai to meet Dr. Shah, the treatment was done online.
The patient had the complaints of trigeminal neuralgia for 22 years. She used to suffer from electric current like pains radiating from her mouth towards the ear and head.
Trigeminal neuralgia discomfort of Mrs. IZ had started after she lost her son in an accident 20 years ago. The patient had gone through a lot of emotional stress ever since then. Also, she had lost her husband 2 years ago.
The patient was taking a lot of medications which included steroids and painkillers to tackle trigeminal neuralgia but got no relief.
Dr. Shah studied this case in detail and prescribed her his trigeminal neuralgia research-based molecules for two months.
Living with a Chronic Condition? Get Expert Guidance.
Talk to Dr. Rajesh Shah — 40+ years of experience in managing chronic conditions with a personalized, long-term approach.
When the first follow-up was given by the patient’s daughter on 1st April 2017, the patient had experienced a gradual relief only since the past 3-4 days.
In the second follow-up of the patient on 13th June 2017, the patient had got some relief. The frequency of her attacks had reduced.
The third follow-up of the patient in August 2017 showed 25% relief in her condition.
The patient reported 50% relief in her fourth follow-up in October 2017. Her pain had turned mild in nature, and only triggers, such as brushing or eating, aggravated the pain.
After a gap in the medication for over a month, when the patient reported her follow-up on 5th in January 2018, there was 70%-80% improvement in her condition.
The latest follow-up of the patient in April 2018 showed an overall 90% improvement in her condition.
The patient is still under the care of Life Force and steadily improving all the more.
Conclusion:
This case highlights that Dr. Shah’s research-based molecules help patients to enhance their pain threshold and minimizes the intensity, frequency, and duration of trigeminal neuralgia attacks.
